Published in Healthcare Finance, Tax and Law Weekly, April 18th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Altea Therapeutics.
Report 1: Altea Therapeutics has entered into research agreements with two undisclosed pharmaceutical companies to examine the feasibility of developing novel transdermal patch products for two protein drugs.
Under the terms of these agreements, Altea Therapeutics will use its patented transdermal delivery technology, the PassPort System, to assess the feasibility of delivering certain proprietary protein drugs from a transdermal skin patch. These...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly